Medicinal Cannabis Matters – A weekly round-up.
Medicinal Cannabis Matters | Friday roundup 24th May 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week we explore CBD-integrated treatments for chiropractic patients, and how the cannabis compound cannabinol could be used as a treatment for Alzheimer’s and Parkinson disease, we also look into the 27 countries of the European union that have legalised medicinal cannabis.
CBD-integrated treatments for chiropractic patients.
There has been a lot of attention on CBD and its potential in recent years. Starting your CBD journey may be trial and error and it is important we understand CBD and its pros and cons for different condition treatments.
Cannabis compound cannabinol could be used as a treatment for Alzheimer’s and Parkinsons’ disease.
Researchers at the Salk Institute have discovered that cannabinol (CBN) may have the potential to treat neurological disorders such as Alzheimer’s and Parkinson’s disease. By analysing data, the researchers broke down CBN into smaller chemicals to identify which components were most effective.
Twenty-one of 27 European countries legalised medicinal cannabis.
Efforts to decriminalise and legalise cannabis for medicinal use are underway across Europe, with 21 out of the 27 European countries having already legalised it.
CBD is everywhere but what do we really know about it?
Cannabidiol commonly known as CBD has had a surge in popularity but what do we actually know about it? In this article, we look into the pros and cons of CBD and the potential benefits.
If you want to know more about medicinal cannabis, then Medicann is the only medicinal cannabis in Jersey and Guernsey that is award-winning and the first consultation is only £50, and free for patients transferring.
Check your eligibility today, and become a patient.
https://www.medicann.co.uk/book-consultation/eligibility
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
